95 related articles for article (PubMed ID: 8362411)
1. Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8.
Hildebrand WH; Domena JD; Parham P
Tissue Antigens; 1993 Apr; 41(4):190-5. PubMed ID: 8362411
[No Abstract] [Full Text] [Related]
2. A single amino acid substitution at residue 167 forms a novel HLA-B51 subtype.
Kawaguchi G; Nakayama S; Nagao T; Takiguchi M
Tissue Antigens; 1993 Jul; 42(1):39-41. PubMed ID: 8248893
[No Abstract] [Full Text] [Related]
3. Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types.
Hurley CK; Steiner N; Hoyer RJ; Menchaca E; Mitton W; Simonis T; Hartzman RJ; Johnson AH; Ng J
Tissue Antigens; 1996 Mar; 47(3):179-87. PubMed ID: 8740766
[TBL] [Abstract][Full Text] [Related]
4. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new HLA-B*08 variant, HLA-B*0804.
Eberle M; Lorentzen DF; Iwanaga KK; Hennes LF; Watkins DI
Tissue Antigens; 1997 Mar; 49(3 Pt 1):256-61. PubMed ID: 9098933
[TBL] [Abstract][Full Text] [Related]
6. Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529, B*3532, B*4025, B*5304 and B*5508.
Kennedy CT; Dodd R; Le T; Wallace R; Ng G; Greville WD; Kennedy A; Taverniti A; Moses JH; Clow N; Watson N; Dunckley H
Tissue Antigens; 2000 Mar; 55(3):266-70. PubMed ID: 10777103
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new HLA-B*08 allele in a family of Iraqi origin.
Buffi O; Nesci S; Iliescu A; Amadei M; Valentini M
Tissue Antigens; 2011 Aug; 78(2):153-4. PubMed ID: 21568943
[TBL] [Abstract][Full Text] [Related]
8. Complete cDNA sequence of B*4406, an HLA-B allele containing sequences of B*5101 and B*4402.
Zhao W; Fernandez-Viña MA; Lazaro AM; Araujo HA; Miller S; Stastny P
Tissue Antigens; 1996 May; 47(5):431-4. PubMed ID: 8795146
[No Abstract] [Full Text] [Related]
9. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
[TBL] [Abstract][Full Text] [Related]
10. Serological and molecular identification of an HLA-B8 variant, HLA-B8Jon (B*0802).
Darke C; Fussell H; Street J; Thomas M; Guttridge MG; Worwood M
Exp Clin Immunogenet; 1996; 13(3-4):139-53. PubMed ID: 9165268
[TBL] [Abstract][Full Text] [Related]
11. A new subtype of HLA-B55 (B*5504) has a hybrid nucleotide sequence between B*5502 and any of the alleles B*4002, B*4005, B*4801 or B*8101.
Marcos CY; Fernández-Viña MA; Lázaro AM; Nulf CJ; Stastny P
Tissue Antigens; 1997 Dec; 50(6):668-70. PubMed ID: 9458125
[No Abstract] [Full Text] [Related]
12. A new HLA-B51 allele, B*5107 in RCE55 detected and characterized by PCR-SSOP, cloning and nucleotide sequence determination.
Curran MD; Williams F; Rima BK; Markwick J; Middleton D
Tissue Antigens; 1996 Sep; 48(3):228-30. PubMed ID: 8896186
[No Abstract] [Full Text] [Related]
13. Characterisation of a new HLA-B allele, HLA-B*0724.
Middleton D; Curran MD; Anholts JD; Reilly ER; Schreuder GM
Tissue Antigens; 2001 May; 57(5):471-3. PubMed ID: 11556973
[No Abstract] [Full Text] [Related]
14. HLA-B8 in juvenile dermatomyositis.
Pachman LM; Jonasson O; Cannon RA; Friedman JM
Lancet; 1977 Sep; 2(8037):567-8. PubMed ID: 95783
[No Abstract] [Full Text] [Related]
15. Frequencies of HLA-DR3, -DR4, -B8 and -Bw62 in diabetic children diagnosed between 1960 and 1990.
Mäenpää A; Koskimies S; Scheinin T; Schlenzka A; Akerblom HK; Mäenpää J; Reunanen A; Kontiainen S
Diabetes Res; 1991 Apr; 16(4):159-63. PubMed ID: 1802481
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel HLA-B51 allele, HLA-B*51:94.
Daskalakis M; Emmerich F; Niemeyer C
Tissue Antigens; 2010 Nov; 76(5):423. PubMed ID: 20663102
[TBL] [Abstract][Full Text] [Related]
17. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.
Ooba T; Hayashi H; Karaki S; Tanabe M; Kano K; Takiguchi M
Immunogenetics; 1989; 30(2):76-80. PubMed ID: 2788131
[TBL] [Abstract][Full Text] [Related]
18. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.
Hayashi H; Ennis PD; Ariga H; Salter RD; Parham P; Kano K; Takiguchi M
J Immunol; 1989 Jan; 142(1):306-11. PubMed ID: 2909619
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel HLA-B*51 variant: HLA-B*5112.
Tamouza R; Visser CJ; El Kassar N; Poirier JC; Toubert A; Bierling P; Raffoux C; Charron D
Tissue Antigens; 1998 Nov; 52(5):489-91. PubMed ID: 9864040
[No Abstract] [Full Text] [Related]
20. Cell surface expression level variation between two common Human Leukocyte Antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains.
Dellgren C; Nehlin JO; Barington T
PLoS One; 2015; 10(8):e0135385. PubMed ID: 26258424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
